Last reviewed · How we verify

Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Rheumatoid Arthritis Refractory to Methotrexate (FARM)

NCT03944096 PHASE2 UNKNOWN

In this 24-week, single center, randomized, double-blind study, the investigators will evaluate the efficacy and safety of fecal microbiota transplantation in patients with active rheumatoid arthritis refractory to methotrexate

Details

Lead sponsorPeking Union Medical College Hospital
PhasePHASE2
StatusUNKNOWN
Enrolment30
Start dateTue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Jul 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China